$DVAX
Market Cap:
$DVAX SEC Filings
| Filing | Filed On |
|---|---|
| FORM 10-K | 06 Mar 2009 |
| Q4 AND YE 2008 FINANCIAL RELEASE | 02 Mar 2009 |
| 8-K FDA | 09 Feb 2009 |
| 8-K NEO COMPENSATION | 02 Feb 2009 |
| AMENDMENT TO SCHEDULE 13D | 29 Dec 2008 |
| MERCK TERMINATION | 19 Dec 2008 |
| GLAXOSMITHKLINE AND DYNAVAX ANNOUNCE WORLDWIDE STRATEGIC ALLIANCE | 17 Dec 2008 |
| DYNAVAX | 12 Dec 2008 |
| SCHEDULE 13D | 11 Dec 2008 |
| UNIVERSAL FLU DATA | 08 Dec 2008 |
| NOTIFICATION OF TRANSFER TO THE NASDAQ CAPITAL MARKET | 25 Nov 2008 |
| NASDAQ NOTIFICATION | 14 Nov 2008 |
| SC 13G/A | 10 Nov 2008 |
| FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 | 06 Nov 2008 |
| FORM 8-A12B | 06 Nov 2008 |
| CURRENT REPORT ON FORM 8-K | 06 Nov 2008 |
| 3Q 2008 FINANCIAL RESULTS | 03 Nov 2008 |
| 3 | 24 Oct 2008 |
| SC 13D | 24 Oct 2008 |
| AMENDMENT NO. 8 | 24 Oct 2008 |
